Sponsor Dossier
GM Pharma
Sponsor Dossier for GM Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ACAMPROSATE-WGR
- Brand: ACARBOSE-WGR
- Brand: ACICLOVIR-WGR
- Brand: ALENDRONATE-WGR
- Brand: Allopurinol-WGR
- Brand: AMISULPRIDE-WGR
- Brand: AMITRIPTYLINE-WGR
- Brand: AMLODIPINE-WGR
About
GM Pharma is an Australian Private Company with ABN 19006286255, registered in Victoria. The entity is active.
Portfolio
GM Pharma has 142 brands on the ARTG, of which 111 are indexable. The company has 110 brands with Product Information on file, 2 brands with at least one PBS-listed item, and 3 brands with PBAC outcomes on record.
Therapeutic focus —
Neurology: 43 brands — Cardiology: 31 brands — Infectious Disease: 20 brands — Endocrinology: 8 brands — Ophthalmology: 7 brands — Gastroenterology: 6 brands — Immunology: 5 brands — Oncology: 5 brands — Urology: 4 brands — Pain & Anaesthesia: 4 brands — Psychiatry: 3 brands — Reproductive Health: 2 brands — Haematology: 1 brand — Dermatology: 1 brand — Musculoskeletal: 1 brand — Pain Management: 1 brand
PBS footprint
GM Pharma has 2 brands with at least one PBS-listed item, with the latest PBS schedule date of 2026-05-01.
Regulatory activity
The company's most recent PBAC outcome is from 2009-11-01, with 3 brands holding PBAC outcomes on record.